Neoplasms Metastasis Completed Phase 2 Trials for Trastuzumab (DB00072)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02004769Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric CancerTreatment